Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Autologous Stem Cell in Liver Cirrhosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Liver cirrhosis of any origin~* Moderate liver disfunction (Child-Pugh Score=7-10)~Exclusion Criteria:~* Waiting time expectancy of liver transplant shorter than 12 months~* Ongoing hepatic encephalopathy~* Clinically detectable ascitis~* Severe coagulation disorder (INR\>2,0 or platelets count \< 40.000)~* Diagnosis or strong suspicion of cancer (except basocellular)~* Pregnancy or intention to become pregnant during the next 12 months~* Moderate or severe co-morbidity~* Current participation in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).